150 related articles for article (PubMed ID: 30640208)
1. CE: Caring for Survivors of Hodgkin Lymphoma.
Lin X; Corcoran S
Am J Nurs; 2019 Feb; 119(2):32-41. PubMed ID: 30640208
[TBL] [Abstract][Full Text] [Related]
2. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
[TBL] [Abstract][Full Text] [Related]
4. Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma.
Hahn EE; Wu YL; Munoz-Plaza CE; Garcia Delgadillo J; Cooper RM; Chao CR
Cancer; 2019 May; 125(9):1558-1567. PubMed ID: 30620388
[TBL] [Abstract][Full Text] [Related]
5. Self-reported competence in long term care provision for adult cancer survivors: A cross sectional survey of nursing and allied health care professionals.
Faithfull S; Samuel C; Lemanska A; Warnock C; Greenfield D
Int J Nurs Stud; 2016 Jan; 53():85-94. PubMed ID: 26412775
[TBL] [Abstract][Full Text] [Related]
6. Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors-A population-based cohort study from Sweden and Denmark.
Glimelius I; Englund A; Rostgaard K; Smedby KE; Eloranta S; de Nully Brown P; Johansen C; Kamper P; Ljungman G; Hjalgrim LL; Hjalgrim H
Cancer Med; 2019 Aug; 8(10):4918-4927. PubMed ID: 31264807
[TBL] [Abstract][Full Text] [Related]
7. [The BETER survivorship care initiative for Hodgkin lymphoma; tailored survivorship care for late effects of treatment].
Dekker N; van 't Veer MB; Aleman BM; van Leeuwen FE; Raemaekers JM
Ned Tijdschr Geneeskd; 2015; 159():A9269. PubMed ID: 26577382
[TBL] [Abstract][Full Text] [Related]
8. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
Leahy Y
Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
[TBL] [Abstract][Full Text] [Related]
9. Survivorship: adult cancer survivors.
Ganz PA
Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
[TBL] [Abstract][Full Text] [Related]
10. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects.
Ng AK
Blood; 2014 Nov; 124(23):3373-9. PubMed ID: 25428219
[TBL] [Abstract][Full Text] [Related]
11. Integration of Pediatric Hodgkin Lymphoma Treatment and Late Effects Guidelines: Seeing the Forest Beyond the Trees.
Ehrhardt MJ; Flerlage JE; Armenian SH; Castellino SM; Hodgson DC; Hudson MM
J Natl Compr Canc Netw; 2021 Jun; 19(6):755-764. PubMed ID: 34214967
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the risk of therapy-associated complications in survivors of Hodgkin lymphoma.
Travis LB
Hematology Am Soc Hematol Educ Program; 2007; ():192-6. PubMed ID: 18024629
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin Lymphoma Survivor Wellness: Development of a Web-Based Intervention.
Amweg LN; McReynolds J; Lansang K; Jones T; Snow C; Berry DL; Partridge AH; Underhill-Blazey ML
Clin J Oncol Nurs; 2020 Jun; 24(3):284-289. PubMed ID: 32441674
[TBL] [Abstract][Full Text] [Related]
14. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
van Leeuwen FE; Ng AK
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
[TBL] [Abstract][Full Text] [Related]
16. Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors.
Tinsley H; Gramatges M; Dreyer Z; Okcu MF; Shakeel O
Pediatr Blood Cancer; 2024 Apr; 71(4):e30855. PubMed ID: 38200619
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported distress in Hodgkin lymphoma across the survivorship continuum.
Troy JD; Locke SC; Samsa GP; Feliciano J; Richhariya A; LeBlanc TW
Support Care Cancer; 2019 Jul; 27(7):2453-2462. PubMed ID: 30377801
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of function-limiting late effects in Hodgkin lymphoma survivors.
Enam N; Chou K; Stubblefield MD
PM R; 2022 Jul; 14(7):811-817. PubMed ID: 34181821
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin lymphoma: the follow-up of long-term survivors.
Hodgson DC
Hematol Oncol Clin North Am; 2008 Apr; 22(2):233-44, vi. PubMed ID: 18395147
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects.
Murphy-Banks R; Kumar AJ; Lin M; Savidge N; Livne E; Parsons SK
Support Care Cancer; 2022 Feb; 30(2):1399-1405. PubMed ID: 34524526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
